Covid-19: Oxford University vaccine shows 70% protection

Covid-19: Oxford University vaccine shows 70% protection The coronavirus vaccine developed by the University of Oxford stops 70% of people developing Covid symptoms, a large-scale trial shows.

It will be seen as a triumph, but it comes off the back of Pfizer and Moderna showing 95% protection.

However, the Oxford jab is far cheaper, and is easier to store and get to every corner of the world than the other two. BBC News

See also:

• Oxford University breakthrough on global COVID-19 vaccine University of Oxford
• Matt Hancock: Life back to normal 'after Easter' BBC News
• Covid risk: 3 people, 3 very different Covid risks. What's yours? BBC News
• Covid: Jab for people who cannot be vaccinated trialled BBC News
• Covid antibodies 'last at least six months' BBC News
• Covid-19: UK 'setting up vaccine hubs ready for roll-out' BBC News
• Arthritis drug and remdesivir combo get emergency FDA approval The Daily Mail
• Coronavirus vaccinations could be under way for ALL adults by the end of January The Daily Mail
• Pfizer sends full results on breakthrough Covid vaccine to drugs watchdogs in UK, US and Europe The Daily Mail
• NHS could start using Covid vaccine next month, says Hancock The Guardian
• Student nurses on Covid placements in UK call for return of paid NHS contracts The Guardian
• Boris Johnson ‘acted illegally’ over jobs for top anti-Covid staff The Guardian
• Oxford Covid vaccine could be final piece of the jigsaw in bringing pandemic to an end The Independent
• UK Covid death toll up 341 in 24 hours, as cases rise by 19,875 The Independent
• Britain to become first country to trial AstraZeneca coronavirus antibody treatment The Independent
• Coronavirus: Military to provide rapid testing in all areas under tier 3 restrictions after England’s lockdown The Independent
• WHO Covid envoy fears third wave of virus in Europe next year The Independent